OBSOLETE: Lymphoproliferative syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
Mar 2025Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2

TrialRECRUITING
Feb 2022Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for OBSOLETE: Lymphoproliferative syndrome.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Phase 2
1Unknown
2Total recruiting
Search clinical trials for OBSOLETE: Lymphoproliferative syndrome

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Lymphoproliferative syndrome.
Search PubMed for OBSOLETE: Lymphoproliferative syndrome

Browse all OBSOLETE: Lymphoproliferative syndrome news →

Specialist Network

No specialists currently listed for OBSOLETE: Lymphoproliferative syndrome.

View all OBSOLETE: Lymphoproliferative syndrome specialists →

Quick Actions